Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | PTPRC | P08575 | 1/20 | 0.35 |
| ▸ | PTPRF | P10586 | 1/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1238056 | 0.98 | MAPT (0.55) | MAPTMAOAMAOBPTPN1PTPRC | |
| SCHEMBL1237586 | 0.89 | MAPT (0.70) | MAPTMAOAMAOBPTPN1PTPRC | |
| SCHEMBL3397911 | 0.87 | MAPT (0.62) | MAPTMAOAMAOBPTPN1PTPRC | |
| SCHEMBL1235852 | 0.87 | MAPT (0.68) | MAPTMAOAMAOBPTPN1PTPRC | |
| SCHEMBL11181983 | 0.84 | MAPT (0.65) | MAPTMAOAMAOBPTPN1PTPRC | |
| SCHEMBL900953 | 0.84 | MAPT (0.70) | MAPTMAOAMAOBPTPN1PTPRC | |
| SCHEMBL6911275 | 0.84 | MAPT (0.59) | MAPTMAOAMAOBPTPN1PTPRC | |
| SCHEMBL10975426 | 0.77 | — | — | |
| SCHEMBL14763707 | 0.74 | MAPT (0.57) | MAPTHIF1ACCR2DAO | |
| SCHEMBL30235867 | 0.72 | MAPT (0.37) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240409486-A1 | COMPOUND PRODUCING METHOD INCLUDING STEP OF ISOMERIZING ALPHA, BETA-UNSATURATED KETONE | KAO CORPORATION (JP) | 2024-12-12 | — | — | US | disclosed |
| CN-118103345-A | Method for producing compound comprising isomerization step of alpha, beta-unsaturated ketone | 花王株式会社 | 2024-05-28 | — | — | CN | disclosed |
| WO-2023063030-A1 | COMPOUND PRODUCING METHOD INCLUDING STEP FOR ISOMERIZING α,β-UNSATURATED KETONE | 花王株式会社 | 2023-04-20 | — | — | WO | disclosed |
| EP-2266943-B1 | METHOD FOR PRODUCING OF 2-ALKYL-2-CYCLOALKEN-1-ONE | KAO CORP (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-8394994-B2 | Method for producing of 2-alkyl-2-cycloalken-1-one | KAO CORPORATION (JP) | 2013-03-12 | — | — | US | disclosed |
| US-20110034722-A1 | METHOD FOR PRODUCING OF 2-ALKYL-2-CYCLOALKEN-1-ONE | KAO CORPORATION (JP) | 2011-02-10 | — | — | US | disclosed |
| EP-1841729-B1 | 2-CYCLOPENTEN-1-ONE OXIME DERIVATIVES INHIBITING PRODUCTION OF TNF-ALPHA | AMOREPACIFIC CORP (KR) | 2011-01-12 | — | — | EP | disclosed |
| EP-2266943-A1 | METHOD FOR PRODUCING OF 2-ALKYL-2-CYCLOALKEN-1-ONE | Kao Corporation (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-3981911-A | Process for preparing (1-oxo-2-cyclopentyl-2-methyl-6,7-dichloro-5-indanyloxy)acetic acid | MERCK & CO., INC. (US) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409486-A1 | COMPOUND PRODUCING METHOD INCLUDING STEP OF ISOMERIZING ALPHA, BETA-UNSATURATED KETONE | CBR1, AKR1B1, AKR1C1 | MAPT 4276/4885MAOA 2548/4885MAOB 1511/4885 |
| US-20110034722-A1 | METHOD FOR PRODUCING OF 2-ALKYL-2-CYCLOALKEN-1-ONE | PAOX, CYP1A1, ADH1A | MAPT 4431/4885MAOA 816/4885MAOB 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.